Suppr超能文献

氟苯尼考对鸭的药代动力学和药效学(PK/PD)建模及PK/PD界值的确定

Pharmacokinetic and Pharmacodynamic (PK/PD) Modeling and Establishment of the PK/PD Cutoff of Florfenicol Against in Ducks.

作者信息

Xiao Xia, Lan Weixuan, Zhao Yaqin, Li Ruichao, Liu Yuan, Liu Juan, Wang Zhiqiang

机构信息

College of Veterinary Medicine, Yangzhou University, Yangzhou, China.

Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, China.

出版信息

Front Microbiol. 2021 Jan 11;11:616685. doi: 10.3389/fmicb.2020.616685. eCollection 2020.

Abstract

can invade and translocate through endothelial cells and result in vascular-system infection, which can cause severe economic losses in the poultry industry. Antibacterial therapy (especially florfenicol) plays an important part in controlling infection. To preserve the effect of florfenicol, pharmacokinetic/pharmacodynamic (PK/PD) modeling of florfenicol against three strains in duck was established. Then, the efficacy of the currently marketed dose, a rational dosage regimen for populations, and the PK/PD cutoff were predicted through Monte Carlo simulations (MCSs). The area under the concentration-time curve from 0 to 24 h/minimum inhibitory concentration (AUC /MIC) was the optimal PK/PD parameter. The PK/PD surrogate values of florfenicol against were similar using different organs as the PD target, but varied in different strains. For the florfenicol-sensitive strain 0825Y, when the AUC /MIC reached 117.54 and 108.19, florfenicol showed a bactericidal effect in the liver and lung, respectively. For the florfenicol-sensitive strain 0901J, the corresponding value was 78.39 and 54.30, respectively. For the florfenicol-resistant strain JY160110, florfenicol could attain a maximum effect of 1 - log reduction in bacteria in the liver and lung when the AUC /MIC reached 2.03 and 2.06, respectively. The PK/PD-based prediction for the population dose indicated a poor effect for the low end of the currently marketed dose (40 mg/kg body weight per day), but a robust effect for the high end of the currently marketed dose (60 mg/kg body weight per day) with a target attainment rate of 92.79% and 81.44% against in mainland China and worldwide, respectively. The recommended dose optimized by MCSs was 52 mg/kg body weight in mainland China. The PK/PD cutoff of florfenicol against at the low end and high end of the current daily dose (40 and 60 mg/kg body weight) and predicted daily dose in mainland China (52 mg/kg body weight) was 0.25, 4, and 0.5 μg/ml, respectively. These results suggested that more than one strain should be involved for PK/PD modeling and contributed to rational use of florfenicol in populations. We also provided fundamental data for determination of florfenicol breakpoints in poultry.

摘要

可侵入并通过内皮细胞转移,导致血管系统感染,这会给家禽业造成严重经济损失。抗菌治疗(尤其是氟苯尼考)在控制感染方面发挥着重要作用。为了保持氟苯尼考的疗效,建立了氟苯尼考对鸭的三种菌株的药代动力学/药效学(PK/PD)模型。然后,通过蒙特卡洛模拟(MCS)预测了当前市售剂量的疗效、针对群体的合理给药方案以及PK/PD临界值。0至24小时浓度-时间曲线下面积/最低抑菌浓度(AUC/MIC)是最佳的PK/PD参数。以不同器官作为药效学靶点时,氟苯尼考对[具体菌株信息缺失]的PK/PD替代值相似,但在不同菌株中有所不同。对于氟苯尼考敏感菌株0825Y,当AUC/MIC分别达到117.54和108.19时,氟苯尼考在肝脏和肺中分别显示出杀菌作用。对于氟苯尼考敏感菌株0901J,相应的值分别为78.39和54.30。对于氟苯尼考耐药菌株JY160110,当AUC/MIC分别达到2.03和2.06时,氟苯尼考在肝脏和肺中对细菌的最大杀菌效果可达1个对数级降低。基于PK/PD的群体剂量预测表明,当前市售剂量的低端(每天40毫克/千克体重)效果不佳,但高端(每天60毫克/千克体重)效果显著,在中国内地和全球针对[具体菌株信息缺失]的达标率分别为92.79%和81.44%。通过MCS优化的推荐剂量在中国内地为52毫克/千克体重。当前每日剂量(40和60毫克/千克体重)以及中国内地预测每日剂量(52毫克/千克体重)下氟苯尼考对[具体菌株信息缺失]的PK/PD临界值分别为0.25、4和0.5微克/毫升。这些结果表明,PK/PD建模应涉及多种菌株,有助于氟苯尼考在群体中的合理使用。我们还为确定家禽中氟苯尼考的断点提供了基础数据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验